LMC Participates in Important Cancer Research
Lexington Medical Center is participating in a clinical trial for breast cancer involving hormone therapy. The trial, sponsored by the American College of Surgeons Oncology Group (ACOSOG), is comparing three FDA-approved hormonal agents that each show promising results treating some breast cancer patients. The goal is to find which drug is best. Ultimately, researchers will compare the most successful drug with traditional chemotherapy.
Lexington Medical Center has referred 12 women so far for a National Cancer Institute-funded study called STORY, which stands for “Sisters Tell Others and Revive Yourself.” The project focuses on African-American women with breast cancer and compares the benefits of a telephone support group to standard psychosocial care. The study hopes to show that women in the telephone support group, who are encouraged to share their story with others, will have better outcomes.
Speaking of this research, Nan Faile said, “The person who wins in this equation is the patient.”
Lexington Medical Center is also taking part in two studies involving tissue banking. The first study is looking at the body’s ability to fight cancer cells. The work centers around factors associated with anti-tumor immunity in cancer patients. The second study looks at the role of a particular protein in the development of cancer cells related to breast and renal cancer.
Faile recently received a Thank You letter form the South Carolina Biorepository System, a statewide tissue banking network. Here is an excerpt: “We are pleased to tell you that LMC is an outstanding model for tissue banking. The high level of organization, efficiency and skill…, the flexibility in meeting the changing needs of the cancer research community and the true passion to further cancer research in South Carolina is remarkable and inspiring.”
These studies are one aspect of the important cancer care to which Lexington Medical Center is dedicated. Lexington Medical Center is the first hospital in South Carolina to perform Microwave Ablation, a treatment that can destroy tumors with a minimally-invasive, outpatient procedure. Lexington Medical Center’s cancer program is also accredited by the American College of Surgeons.